In the kynurenine/tryptophan pathway, indole-3-carboxylate, kynurenine, and kynurenic acid were elevated in cognitively improved patients, whereas 5-Hydroxyindoleacetic acid (5-HIAA) was reduced among patients with gait improvement
"I get emails from my patients, [saying] 'can you upgrade me to this better medication I heard [about] on TikTok'," she said
Cori Ritchey, C.S.C.S., is the fitness editor at Women's Health , as well as a certified strength and condition coach and group fitness instructor
What factors of GLP-1 coverage drive up premiums Using data from MarketScan and research by Blue Health Intelligence (BHI), the EBRI report models how GLP-1 coverage could affect employer-sponsored insurance premiums, exploring several scenarios based on: Drug pricing Net costs range from $617 to $766 per 30-day supply Patient adherence Perfect adherence leads to higher premiums due to sustained drug use Eligibility criteria Including overweight individuals with at least one weight-related condition significantly increases cost burden Cost-sharing Cost-sharing structures such as $90 copays help but dont eliminate increases Usage is growing More than 57 million privately insured adults qualify for GLP-1 drugs, like Ozempic and Wegovy